Breathalyzers Can't Catch What's on the Road Today.

Dr. Joel Ehrenkranz, founder of Oculometrix, is a physician-scientist, serial biotech entrepreneur, and recognized expert in medical diagnostics, neuroendocrinology, public safety technologies, and biomedical product commercialization. He serves as a Visiting Professor in the Division of Chemistry and Chemical Engineering at the California Institute of Technology (Caltech) and as Associate Professor of Endocrinology at the University of Colorado School of Medicine. Board-certified in internal medicine and endocrinology, Dr. Ehrenkranz brings a rare combination of scientific depth, clinical expertise, regulatory insight, and entrepreneurial experience to the development of scalable technologies that improve human health, safety, and performance.

A graduate of Stanford University School of Medicine, Dr. Ehrenkranz completed postgraduate training in internal medicine at Bellevue Hospital and Columbia University College of Physicians and Surgeons, neurology at Memorial Sloan Kettering Cancer Center, and endocrinology at the National Institutes of Health. He has held faculty appointments at Columbia University and the University of Utah and previously served as a consultant and advisor to the Commissioner of the U.S. Food and Drug Administration (FDA).

Dr. Ehrenkranz has founded four biotechnology companies and contributed to the development and commercialization of multiple innovative healthcare technologies, including home pregnancy tests, drug testing systems, point-of-care endocrine diagnostics, therapies for diabetes and osteoporosis, newborn screening technologies, and smartphone-based medical platforms. His work has consistently focused on transforming advanced science and engineering into practical, scalable products capable of broad market adoption, particularly through low-cost, globally available consumer hardware platforms.

Dr. Ehrenkranz brings extensive experience in correctional medicine, forensic diagnostics, public health, and law enforcement technologies. His clinical research at the Connecticut Maximum Security Penitentiary and service as Medical Director of Arizona State Prisons in Douglas and Tucson provided direct operational insight into the real-world challenges of identifying impaired individuals in law enforcement environments. These experiences reinforced his long-standing view that public health and public safety are fundamentally interconnected and highlighted the need for objective, technology-driven methods of assessing human performance and impairment.

This combination of clinical medicine, neuroscience, AI-enabled diagnostics, regulatory knowledge, and operational public safety experience directly shaped the vision behind Oculometrix: a scalable digital platform for objective physiological and neurocognitive assessment. While the company's initial applications focus on impairment detection and law enforcement, the underlying technology has broad potential across transportation safety, industrial workforce monitoring, sports medicine, concussion screening, neurological and psychiatric disease management, and other safety-sensitive industries. By leveraging the computational power and global availability of modern smartphones, Oculometrix aims to deliver sophisticated human performance analytics worldwide in formats that are affordable, portable, easy to use, and scalable.

Chi Hoang serves as Chief Technology Officer of Oculometrix, leading the company's technical development across ML model architecture, on-device inference, and system infrastructure.

At LinkedIn's AI Infrastructure team, Hoang engineers AutoResearch, a platform that uses an AI-driven planner to autonomously optimize the models behind LinkedIn's recommendation systems, dramatically reducing manual tuning effort. She previously built a failure-analysis system that processed over 1M engineering incidents and cut on-call workload by 200 hours, and has shipped monitoring dashboards tracking performance across production systems. Her current work involves coordinating and evaluating specialized AI agents within LinkedIn's model-training automation platform.

Before LinkedIn, Hoang built an AI-powered accessibility compliance system and deployment infrastructure at GeoProspex (formerly Dodda AI), a Techstars-backed land intelligence startup ($135B portfolio). At Caltech, she was selected as a first-year for the Summer Undergraduate Research Fellowship (SURF), developing a feature for gget — a biology research tool with 70,000+ GitHub downloads — that cut a key query from five minutes to ten seconds; the work was published in Oxford's Bioinformatics. She also interned at the U.S. House of Representatives for Congresswoman Bonnie Watson Coleman, writing policy memos, attending briefings on data, energy, and economic policy, and assisting New Jersey constituents.

Hoang holds a B.S. in Computer Science from the California Institute of Technology (Caltech).

Steven E. Feldon, M.D., M.B.A, Emeritus Professor and Chair of the University of Rochester School of Medicine & Dentistry, is a neuro-ophthalmologist. He currently serves as the President of the Alliances for Eye and Vision Research (AEVR/NAEVR). He is the immediate past Executive Vice President of the American University of Professors in Ophthalmology (AUPO) and is the Chief Executive of AUPO Connect, LLC., a Group Purchasing Organization.

A graduate of UCLA (BA, 1969) and Albert Einstein College of Medicine (MD, 1973), his post-graduate training was completed at Mass. Eye & Ear Infirmary and UC, San Francisco. He served as president of the North American Neuro-ophthalmology Society and has authored more than 100 peer-reviewed scientific publications. He holds 8 patents. Amongst his inventions is the Tonopen®, the most commonly used hand-held tonometer for measurement of intraocular pressure. He also pioneered electronic medical records with the introduction of the OcuChart™ in 1993. These inventions were manufactured, marketed, and distributed by companies founded and led by Dr. Feldon. His current sponsored research is focused on Thyroid Eye Disease.

Dr. Feldon is on the Board of Directors of the Doheny Eye Institute and Excell Partners, an early round venture capital group affiliated with the University of Rochester. He serves on the Scientific Advisory Board of Empire Discovery Institute, a NY State sponsored organization promoting drug discovery for Western New York.

Mitch has over thirty-five years of investment banking experience and has completed transactions involving all areas of mergers and acquisitions, equity fund raisings, debt financing, balance sheet management and hedging, corporate restructurings, film financings and leveraged buyouts.

He began his career with Bankers Trust in the US and moved to London with them in 1983. There, he covered corporate clients across Europe in the debt and capital markets areas. Later, with NatWest Markets/Hawkpoint Partners, he was head of marketing for the Debt Structuring Group and a Director of Corporate Finance covering the Media and Technology sectors. He went on to be an original member of LongAcre Partners, the media and telecoms advisory boutique backed by the partners of the Olswang law firm and the Corsair Fund where he served as a Managing Director before he left to co-found Noventus in 2002.

He holds a BA from Columbia, a JD from NYU Law School and an MBA from Columbia Business School and is a member of the New York Bar.

Chief Chris Burbank is a recognized public speaker and authority on issues surrounding policing, especially as they pertain to public interaction. He regularly participates with media nationally and internationally to bring clarity to current critical events and situations.

Chris participated with the Center for Policing Equity (CPE) from its inception in 2008 until 2025, originally as an advisory board member and then as a vice president following his retirement from Salt Lake City Police Department in 2015. During his tenure with CPE, the organization grew from seven passionate individuals to the nation's largest research-driven, justice-in-policing organization, raising over $80 million with 150 employees throughout the country. CPE demonstrated the transformative impact of data-driven interventions, partnering with 60 law enforcement agencies in 30 states, serving over 85.2 million people.

Chris is a recognized expert in law enforcement. He testified before Congress on three occasions, advised the U.S. Department of Justice on consent decrees, and serves as an expert witness on cases involving all aspects of policing including use of force, search and seizure, wrongful death, and civil rights.

Chris served the Salt Lake City Police Department from 1991 until his retirement in June 2015. He was appointed to the position of Chief in 2006, becoming the 45th Chief of the Department. During his nine-year tenure he distinguished himself as progressive and innovative, influencing not only the City of Salt Lake but also the profession nationally. He was selected as a member of the “Enlightened Fifty” most influential leaders in the State of Utah, and was one of six Police Chiefs in the nation selected to meet with President Barack Obama to discuss the Administration's plan regarding gun violence in America.

Fred Ross is a decorated law enforcement leader with more than three decades of command experience across municipal, metropolitan, and transit policing in Utah. He has served as Chief of Police of both the Utah Transit Authority and Provo City, and as Deputy Chief of the Salt Lake City Police Department — advancing through every level of command and earning a national reputation for progressive, data-driven institutional reform.

Over a twenty-year career with the Salt Lake City Police Department, Ross advanced to serve as Deputy Chief of both the Investigations Division and the Metro Support Division, overseeing 65 detectives conducting major investigations in homicide, assault, robbery, and narcotics. He led a landmark multi-agency initiative targeting Salt Lake City's highest-crime corridor — reducing area crime through targeted resource deployment and nationally recognized diversion programming — for which he received the Salt Lake City Humanitarian Award, the department's first and only. As Chief of Police for the Utah Transit Authority, overseeing an $11.2 million annual budget, 85 sworn officers, and security operations across 45 million annual riders in seven counties, he transformed an underperforming department through systematic reform. He established Utah's first partnership with the Center for Policing Equity, built a real-time crime center staffed by detectives analyzing multi-site surveillance, launched UTA's first K-9 unit, and secured federal Transit Safety Grant funding to develop an anti-terrorism education and security program for the regional rail network. He subsequently served as Chief of Police for Provo City.

Ross advises Oculometrix on field deployment strategy, officer workflow integration, and the practical demands of roadside law enforcement — bringing direct command-level perspective to a device built for the field.